Rays of Belief IPO: Complete Analysis, Dates, and Financial Insights
The healthcare and special education sector is garnering immense attention from the investor community as awareness around neurodevelopmental care increases. The upcoming Rays of Belief IPO represents a fresh opportunity for market participants looking to diversify their portfolios into impact-driven enterprises. Scheduled to hit the public markets in early September 2026, this mainboard public offering aims to raise capital for substantial capacity building and global expansion.
This comprehensive guide delves deeply into the business model, valuation, financial stability, and future prospects of the company, providing you with all the essential data required to stay informed about this book-built issue.
Business Overview: What Does Rays of Belief Do?
Founded in 2017, Rays of Belief Ltd. operates as a for-profit social enterprise specializing in neurodevelopmental disorders (NDDs). Functioning primarily under the well-known brand name Mom's Belief, the organization provides tailored intervention plans for children experiencing conditions such as Autism Spectrum Disorder (ASD), ADHD, Down Syndrome, Cerebral Palsy, and various learning disabilities.
Since inaugurating its first facility in Gurgaon in 2018, the enterprise has demonstrated aggressive growth. As of March 2026, the company boasts an operational footprint of 136 centers spread across 57 cities and 20 states in India. A strategic focus on semi-urban and underserved areas has led to a robust presence in Tier 2 and Tier 3 cities.
Essential IPO Offer Details
The company is aiming to raise ₹125.00 Crores entirely through a fresh issuance of equity. There is no Offer for Sale (OFS) component, meaning all generated funds will go directly to the company rather than existing shareholders. Here are the core specifications of the offering:
| Feature | Details |
|---|---|
| Issue Type | Book Built Issue (Mainboard) |
| Total Issue Size | ₹125.00 Crores (5,230,000 Equity Shares) |
| Face Value | ₹10 per equity share |
| Price Band | ₹227 to ₹239 per share |
| Minimum Lot Size | 62 Shares |
| Listing Platforms | BSE and NSE |
IPO Timeline and Progress Schedule
The bidding window for this IPO is notably tight. Investors must keep track of the following timeline to ensure their applications and subsequent mandate approvals are completed without delays.
Investment Categories and Lot Sizes
To accommodate different tiers of investors, the company has structured specific minimum and maximum bidding limits. Retail investors must invest a minimum of ₹14,818, while High Net-worth Individuals (HNIs) have separate thresholds.
| Investor Category | Lots Required | Total Shares | Investment Amount (at Upper Band) |
|---|---|---|---|
| Retail (Minimum) | 1 Lot | 62 Shares | ₹14,818 |
| Retail (Maximum) | 13 Lots | 806 Shares | ₹1,92,634 |
| Small HNI (Minimum) | 14 Lots | 868 Shares | ₹2,07,452 |
| Small HNI (Maximum) | 67 Lots | 4,154 Shares | ₹9,92,806 |
| Big HNI (Minimum) | 68 Lots | 4,216 Shares | ₹1,007,624 |
Reservation Allocation: Qualified Institutional Buyers (QIB) will receive not less than 75% of the net issue, Non-Institutional Investors (NII) are capped at a maximum of 15%, and Retail Individual Investors are allocated a maximum of 10%.
Financial Health and Track Record
An examination of the restated standalone financial statements indicates significant top-line revenue growth, albeit with slight pressure on net profitability margins in the most recent fiscal year.
| Financial Metric (₹ in Crores) | FY Ending Mar 2024 | FY Ending Mar 2025 | FY Ending Mar 2026 |
|---|---|---|---|
| Total Assets | 12.89 | 26.12 | 50.89 |
| Total Income (Revenue) | 30.76 | 36.54 | 82.06 |
| Profit After Tax (PAT) | 0.85 | 5.88 | 4.96 |
| Net Worth | 5.78 | 15.02 | 30.81 |
| Total Borrowings | - | 4.36 | 3.61 |
Valuation and Key Performance Indicators (KPIs)
Before considering participation, market participants typically analyze the underlying valuation metrics. Here are the critical performance indicators based on FY26 data:
- Return on Equity (ROE): 21.64% (down from 56.56% in FY25)
- Return on Capital Employed (ROCE): 29.74%
- Debt-to-Equity Ratio: 0.12 (indicating a highly unleveraged balance sheet)
- PAT Margin: 6.07%
- Price to Earning (P/E) Ratio: Between 75.63x (Pre-IPO) and 100.84x (Post-IPO)
- Post-issue Market Capitalization: Approximately ₹499.55 Crores
Strategic Objectives of the Issue
The net proceeds generated from this fresh equity issuance have been earmarked for structured expansion and operational strengthening. The core objectives include:
- ₹26.88 Cr designated for establishing new Company Learning Centres and licensing partnerships.
- ₹14.45 Cr to cover lease payments for existing infrastructure in India.
- ₹10.21 Cr dedicated to broad brand awareness and inclusive community outreach programs.
- ₹10.13 Cr allocated as an investment into the US subsidiary to manage lease and license operations in the American market.
- ₹5.54 Cr to foster School Collaboration Centres.
- Remaining funds are slated for technological infrastructure, R&D, upskilling academies, and general corporate purposes.
SWOT Analysis of Rays of Belief Ltd.
Analyzing the strengths, weaknesses, opportunities, and threats provides a balanced perspective of the company's market positioning.
- Strengths: Market pioneer in a highly specialized sector (neurodevelopmental disorders); vast geographic spread with 136 centers; strong multi-disciplinary team comprising over 340 clinical professionals.
- Weaknesses: High valuation multiples (P/E over 100x post-IPO); slight contraction in Profit After Tax (PAT) margins in the latest financial year despite doubling revenues.
- Opportunities: Vast untapped market in Tier 2 and Tier 3 Indian cities; lucrative dollar-revenue potential through the newly acquired US subsidiary; rising awareness regarding early child development and therapy.
- Threats: Changes in healthcare and data privacy regulations; difficulty in retaining highly specialized clinical talent; emerging competition from regional healthcare providers.
Promoter Holding and Management
The enterprise is driven by a committed leadership team. The principal promoters of the company are Mr. Nitin Bindlish and Carving Futures Pte. Ltd.
- Pre-Issue Promoter Shareholding: 92.93%
- Post-Issue Public Float: 7.07%
Important Contacts and Intermediaries
If investors have queries regarding the allotment status, application technicalities, or corporate data, the following official intermediaries can be contacted:
Email for grievances/queries: robl.ipo@kfintech.com
Lead Manager: Mefcom Capital Markets Ltd.
Corporate Office: Rays of Belief Ltd., J-1919, Basement, Chittranjan Park, New Delhi - 110019
Email: cs@momsbelief.com
Summary and Takeaways
The Rays of Belief IPO brings a unique proposition to the Indian primary market, bridging the gap between social impact and for-profit healthcare models. With robust revenue scaling, an expanding footprint in both domestic and international markets, and a largely debt-free status, the business displays strong fundamental mechanics.
However, the aggressive pricing—resulting in a high P/E ratio—coupled with a slight dip in recent profit margins demands careful consideration. Potential stakeholders should assess their risk appetite and weigh the social-impact nature of the business against traditional valuation parameters before making a decision.